New drug TB006 aims to ease Parkinson's symptoms in Early-Stage patients
NCT ID NCT06773962
First seen Oct 31, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study tests an experimental drug called TB006 in 62 people with early-stage Parkinson's disease. The goal is to see if it safely improves motor function and reduces symptoms. Participants receive either TB006 or a placebo, and researchers track changes in movement and overall disease severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel Rocky Mountain Clinical Research
Englewood, Colorado, 80113, United States
-
Central Texas Neurology Consultants
Round Rock, Texas, 78681, United States
-
Consultants in Neurology, Ltd
Northbrook, Illinois, 60062, United States
-
Josephson Wallack Munshower Neurology - Southeast
Indianapolis, Indiana, 46256, United States
-
NYU Langone Health
Patchogue, New York, 11772, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida, 33486, United States
-
Parkinson's Research Centers of America - Long Island
Commack, New York, 11725, United States
-
Parkinson's Research Centers of America - Orange County
Aliso Viejo, California, 92656, United States
-
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California, 94301, United States
-
Quest Research Institute
Farmington Hills, Michigan, 48334, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of South Florida Parkinson's and Movement Disorders Center
Tampa, Florida, 33613, United States
Conditions
Explore the condition pages connected to this study.